Thermo Fisher Scientific Completes $1B Share Repurchase

WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the repurchase of $1 billion (1.9 million shares) of its common stock. As of December 3, 2024, $3 billion remained available under the company’s share repurchase authorization.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241204111636/en/

Media:
Sandy Pound
781-622-1223
[email protected]

Investor:
Rafael Tejada
781-622-1356
[email protected]

Source: Thermo Fisher Scientific Inc.

You May Also Be Interested In

• Bernstein SocGen Group Resumes Thermo Fisher Scientific (TMO) at Market Perform
• SITE Centers Announces Sale of The Pike Outlets and Special Common Distribution
• Mortgage Matchup Named Presenting Sponsor of the 2026 Cranbrook Tennis Classic